Ipamorelin IP5 5mg*10vials

Iparrelin IP5 5mg x 10 Vials

Product Overview

Iparrelin IP5 is an advanced highly efficient optimized growth hormone-releasing pentapeptide, serving as an upgraded high-concentration version of the classic growth hormone peptide product IP2. Utilizing fifth-generation molecular structure optimization technology, IP5 supports GHS-R1a receptor activation efficiency further enhancement research, molecular anti-degradation properties research, and in vivo metabolic stability research. It retains the core highly selective physiological pulsatile growth hormone release mechanism, supporting cortisol and prolactin secretion interference related studies, and non-selective growth hormone secretagogues hormonal side effects related avoidance research. Its high-standard 5mg concentrated formulation is suitable for medium- to high-dose gradient efficacy studies, high-intensity tissue repair modeling, significant body component regulation mechanism validation, and preclinical experiments involving long-term high-dose intervention of the growth hormone axis. It serves as a high-quality highly efficient core research raw material for endocrine metabolism and advanced metabolic research.

Core Research Functions

Growth Hormone-Releasing Peptide Receptors Efficient Activation and Strong Physiological Pulsatile Release: Supports growth hormone-releasing peptide receptors efficient activation research, strong physiological pulsatile release of endogenous growth hormone triggering studies, and human body natural growth hormone secretion rhythm mimicry research.

Stronger Significant Downstream Phenotypic Effects and Intuitive Experimental Data: Supports stronger significant downstream phenotypic effects research compared to low-dose IP2, providing more intuitive experimental data for accelerated lean muscle protein synthesis mechanism exploration, efficient lipolysis activation, bone remodeling, and damaged tissue repair research.

Extremely High Receptor Specificity and Off-Target Hormone Interference Elimination: Supports extremely high receptor specificity research, off-target hormone interference elimination studies, ensuring experimental result purity and accuracy research.

Age-Related Growth Hormone Axis Dysfunction and Body Composition Imbalance In-Depth Research: Supports age-related growth hormone axis dysfunction in-depth research, moderate to severe body composition imbalance studies, bone metabolic dysfunction research, muscle damage repair research, and high-dose complex peptides synergistic effects validation research.

High Discrimination Reproducible Stable Data Support for Advanced Growth Hormone Pathway Mechanism Research: Supports high discrimination reproducible stable data provision research for advanced growth hormone pathway mechanism research.

In professional laboratory studies, Iparrelin IP5 supports growth hormone-releasing peptide receptors efficient activation research, strong physiological pulsatile release of endogenous growth hormone triggering studies, and human body natural growth hormone secretion rhythm mimicry research. Compared to low-dose IP2, IP5 supports stronger significant downstream phenotypic effects research, providing more intuitive experimental data for accelerated lean muscle protein synthesis mechanism exploration, efficient lipolysis activation, bone remodeling, and damaged tissue repair research. IP5 supports high discrimination reproducible stable data provision research for advanced growth hormone pathway mechanism research.

Core Product Advantages

Advanced Efficient Upgrade of IP5: The fifth-generation optimized molecular structure supports target binding activity and molecular stability significant improvement research compared to IP2 and traditional iparene. While maintaining high selectivity, it supports stronger secretion-stimulating efficacy and more significant experimental phenotypes research.

Pure Highly Selective Growth Hormone Secretion Mechanism: Supports GHS-R1a pathway precise targeting research, orderly pulsed growth hormone release induction studies, cortisol and prolactin excessive secretion stimulation related studies, effectively reducing experimental confounding factors and ensuring research data purity research.

5mg High-Concentration Professional Specification: An upgraded medium-to-high dose specification, supporting low-dose version insignificant efficacy related problem research. Suitable for high-dose gradient screening, high-intensity metabolic intervention, long-term continuous modeling, and complex peptide formulation research.

Pharmaceutical-Grade Lyophilization Process: Employs aseptic vacuum lyophilization technology to support inherent peptide activity stable retention research. Each batch undergoes rigorous HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA), supporting low impurity content and excellent batch consistency research.

Standard 10-Vial Aseptic Packaging: 10 vials per box, integrated aseptic packaging, suitable for long-term strategic reserves in laboratories, university key endocrinology research projects, advanced preclinical pharmaceutical research and development, and global bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 5mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).